Table 2.
Survival outcomes according to stage
| Stage I (n = 12) | Stage II (n = 28) | Stage III (n = 33) | Stage IV (n = 3) | All patients (n = 76) | |
|---|---|---|---|---|---|
| Locoregional recurrence, n (%)∗ | 0 (0.0) | 4 (14.3) | 8 (24.2) | 1 (33.3) | 13 (17.1) |
| Distant recurrence, n (%)∗ | 0 (0.0) | 8 (28.6) | 14 (42.4) | 1 (33.3) | 23 (30.3) |
| PFS (%) | |||||
| 3 y | 100.0 | 78.0 | 54.5 | 33.3 | 69.5 |
| 5 y | 100.0 | 70.2 | 50.9 | 0.0 | 63.7 |
| OS (%) | |||||
| 3 y | 100.0 | 78.0 | 57.6 | 33.3 | 70.8 |
| 5 y | 100.0 | 74.1 | 57.6 | 0.0 | 69.3 |
Abbreviations: OS = overall survival; PFS = progression-free survival.
∗
Recurrence rates are based on cumulative incidence.